
Influensasäsongen börjar tidigt: UKHSA uppmanar berättigade grupper att vaccinera sig
Granskad av Dr Colin Tidy, MRCGPFörfattad av Thomas Andrew Porteus, MBCSUrsprungligen publicerad 31 Oct 2025
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ljudversion
- Lägg till i föredragna källor på Google
The UK Health Security Agency (UKHSA) is urging everyone eligible for a free flu vaccination to book their appointment as soon as possible, as flu activity continues to rise across England. The latest surveillance data show that this year’s flu season has started earlier than usual, with a sharp increase in cases among children and signs of growing spread in the wider community.
Early rise in flu activity
According to the latest UKHSA report, flu (influenza) activity is now above the usual baseline for this time of year. Hospital admissions for flu have increased from 1.74 to 2.19 per 100,000 people, with 247 new admissions reported this week alone. Among children aged 5 to 14, the proportion testing positive for flu in hospital settings rose steeply from 20% to nearly 31% in a single week.
Dr Alex Allen, Consultant Epidemiologist at UKHSA, said the early start to the flu season is a cause for concern.
“We’re seeing an unusually early start to the flu season this year, with the latest data showing a sharp increase among children but also increases in other age groups, with the virus now starting to spread more widely in the community,” he said.
“If you’re eligible for a vaccine it is because you are at greater risk of severe illness - every year we see many thousands end up in hospital and far too many deaths from flu. It’s crucial that everyone eligible books their appointment as soon as possible. The vaccine is our best defence.”
Who should get vaccinated
The flu vaccine is offered free on the NHS to those most at risk of serious illness. This includes adults aged 65 and over, pregnant women, and people with certain long-term health conditions such as diabetes, heart disease, or chronic respiratory illness.
Parents are also being reminded to ensure their children are protected. School-age children can receive the nasal spray flu vaccine through school vaccination programmes, while parents of two and three-year-olds should arrange appointments with their GP practice.
Dr Allen added that vaccinating children plays a key role in protecting vulnerable groups. “The nasal spray vaccine can help stop your child from getting very unwell and reduce the risk of passing flu to vulnerable family members,” he said.
Other respiratory viruses remain stable
While flu cases are climbing, COVID-19 activity has decreased and is now circulating at baseline levels. COVID-19 hospital admissions dropped to 2.52 per 100,000 from 3.37 the previous week, and intensive care admissions remain low. Respiratory syncytial virus (RSV) activity has been mixed, with overall hospital admission rates falling slightly.
UKHSA’s weekly surveillance also notes that emergency department attendances for bronchiolitis, a common winter illness caused by RSV in young children, remain stable.
Staying well this winter
As colder weather arrives, public health experts are emphasising the importance of protecting yourself and those around you from winter illnesses. Vaccination remains the best defence against flu and COVID-19 for those eligible.
Anyone experiencing flu or COVID-19 symptoms - including a high temperature, cough, or feeling tired and achy - is advised to minimise contact with others, especially those who are vulnerable. If you need to go out while unwell, consider wearing a face covering, keep indoor spaces well ventilated, and wash your hands regularly.
The UKHSA will continue to monitor trends in flu, COVID-19, and other respiratory infections through its weekly surveillance reports in the weeks ahead.
Patient picks

Hälsonyheter
How to keep your medicines safe during hot weather
When the weather turns hot, most of us remember sunscreen and water. But what about our medicines? Heat can quietly damage medicines, making them less effective or even unsafe. As heatwaves become more common in the UK and globally, knowing how to store medicines properly is becoming essential.
by Dipa Kamdar

Hälsonyheter
What the new generic diabetes and heart medicine means for you: dapagliflozin explained
A major change to one of the NHS’s most widely used diabetes and heart medicines could save hundreds of millions of pounds and make proven treatments more accessible to thousands of patients across the UK. The change centres on dapagliflozin - a medicine used to treat type 2 diabetes, heart failure and certain kidney conditions. It belongs to a family of drugs called SGLT2 inhibitors - sometimes called 'flozins' - which have been described as one of the most important advances in diabetes and heart care in the last decade. Now that the medicine’s patent has been ruled invalid, generic dapagliflozin, identical in safety and effectiveness to the branded version, can be prescribed on the NHS at a much lower cost.
av Thomas Andrew Porteus, MBCS
Om författarenVisa fullständig biografi

Thomas Andrew Porteus, MBCS
Hälsoteknik
MBCS
Thomas skriver för att informera, inspirera och utrusta praktikledare och vårdpersonal som navigerar förändringar, med utgångspunkt i två decennier av praktiskt arbete inom det brittiska hälsosystemet.
Om recensentenVisa fullständig biografi

Dr Colin Tidy, MRCGP
Allmänläkare, Medicinsk Författare
MBBS, MRCGP, MRCP (Paediatrics), DCH
Dr Colin Tidy är en NHS-läkare, baserad i Oxfordshire.
Artikelhistorik
Informationen på denna sida är granskad av kvalificerade kliniker.
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Next review due: 31 Oct 2028
31 Oct 2025 | Ursprungligen publicerad
Författad av:
Thomas Andrew Porteus, MBCSGranskad av
Dr Colin Tidy, MRCGP

Fråga, dela, anslut.
Bläddra i diskussioner, ställ frågor och dela erfarenheter inom hundratals hälsorelaterade ämnen.

Känner du dig sjuk?
Bedöm dina symtom online gratis
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.
Mer inom hälsonyheter
- 1 av 5 barn som börjar grundskolan är inte fullt skyddade mot allvarliga sjukdomar
- NyKan vicka på lillfingret verkligen stoppa kognitiv nedgång?
- Förändringar i vården av typ 2-diabetes - vad det betyder för dig
- Behöver du verkligen gå 10 000 steg om dagen?
- Ebolautbrott förklarat som en global hälsokris - vad du behöver veta
- Gratis vaccin mot vattkoppor erbjuds för första gången till barn i England
- Gratis akut-p-piller nu tillgängligt på apotek i Storbritannien
- NyHow to keep your medicines safe during hot weather
- Mässling är tillbaka: varför vacciner är viktiga
- Medicinska cannabisrecept - fakta bakom rubrikerna
- MHRA godkänner teplizumab för att fördröja utvecklingen av typ 1-diabetes
- Mounjaro prishöjning lämnar brittiska patienter med stora räkningar
- Mounjaro prishöjning: dina frågor besvarade
- NyLäkemedel mot äggstockscancer godkänt för användning inom NHS kommer att förlänga liv
- NHS 10-års hälsoplan förklarad
- TikToks 'nonnamaxxing'-trend förklarad: så här kan livet som en italiensk mormor gynna hälsa och välbefinnande
- What the new generic diabetes and heart medicine means for you: dapagliflozin explained
- Why doctors are striking and how to get help if you need it